Boone Capital Management is an investment fund managing more than $317 billion ran by Paul Iii. There are currently 13 companies in Mr. Iii’s portfolio. The largest investments include Unum and Cigna, together worth $79.8 billion.
As of 7th November 2023, Boone Capital Management’s top holding is 867,565 shares of Unum currently worth over $42.7 billion and making up 13.5% of the portfolio value.
Relative to the number of outstanding shares of Unum, Boone Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 129,917 shares of Cigna worth $37.2 billion, whose value fell approximately 0.1% in the past six months.
The third-largest holding is Molina Healthcare Inc worth $37.1 billion and the next is Danaher worth $32 billion, with 129,163 shares owned.
Currently, Boone Capital Management's portfolio is worth at least $317 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Boone Capital Management office and employees reside in Atlanta, Georgia. According to the last 13-F report filed with the SEC, Paul Iii serves as the CCO, CFO, and COO at Boone Capital Management.
In the most recent 13F filing, Boone Capital Management revealed that it had opened a new position in
Globus Med Inc and bought 428,452 shares worth $21.3 billion.
The investment fund also strengthened its position in Unum by buying
10,000 additional shares.
This makes their stake in Unum total 867,565 shares worth $42.7 billion.
Unum soared 6.7% in the past year.
On the other hand, there are companies that Boone Capital Management is getting rid of from its portfolio.
Boone Capital Management closed its position in Abbvie Inc on 14th November 2023.
It sold the previously owned 88,026 shares for $11.9 billion.
Paul Iii also disclosed a decreased stake in Baxter International by 0.3%.
This leaves the value of the investment at $17.7 billion and 469,405 shares.
The two most similar investment funds to Boone Capital Management are Strategies and Petix & Botte Co. They manage $317 billion and $317 billion respectively.
Boone Capital Management’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 71.5% of
the total portfolio value.
The fund focuses on investments in the United States as
84.6% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
46% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $49.9 billion.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Unum Group |
1.17%
867,565
|
$42,675,522,000 | 13.46% |
| Cigna Group (The) |
17.52%
129,917
|
$37,165,356,000 | 11.72% |
| Molina Healthcare Inc |
6.25%
113,178
|
$37,109,934,000 | 11.71% |
| Danaher Corp. |
17.52%
129,163
|
$32,045,340,000 | 10.11% |
| Enovis Corporation |
17.52%
502,731
|
$26,509,006,000 | 8.36% |
| AMGEN Inc. |
17.52%
98,126
|
$26,372,344,000 | 8.32% |
| Biogen Inc |
52.86%
96,115
|
$24,702,516,000 | 7.79% |
| Globus Med Inc |
Opened
428,452
|
$21,272,642,000 | 6.71% |
| Baxter International Inc. |
31.74%
469,405
|
$17,715,345,000 | 5.59% |
| Quanterix Corp |
13.45%
568,544
|
$15,430,284,000 | 4.87% |
| IDEAYA Biosciences, Inc. |
14.96%
570,682
|
$15,397,000,000 | 4.86% |
| Mirum Pharmaceuticals Inc |
Opened
389,791
|
$12,317,396,000 | 3.89% |
| Abbvie Inc |
Closed
88,026
|
$11,859,743,000 | |
| Cerevel Therapeutics Hldng I |
Closed
300,000
|
$9,537,000,000 | |
| Computer Programs & Sys Inc |
Closed
349,245
|
$8,622,859,000 | |
| BridgeBio Pharma Inc |
Opened
313,381
|
$8,263,857,000 | 2.61% |
| No transactions found | |||
| Showing first 500 out of 16 holdings | |||